Clinical Trial Update: The Effective and Safety of Thalidomide in NTDT [Phase 2]

View source ↗

Summary

Trial update on the effectiveness and safety of thalidomide in non-transfusion-dependent thalassemia (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-transfusion-dependent Thalassemia
• Thalassemia

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Xiao-Lin Yin | Conditions: Thalassemia | Phase 2 | Status: UNKNOWN